Stryker announced FDA clearance of the 3-D printed
Tritanium PL Posterior Lumbar Cage, marking another step in its strategy
to deploy the new additive manufacturing technology to create new
products and earn incremental revenue growth.
The device is made from novel, highly porous
titanium material designed for bone ingrowth and fixation in spinal
conditions like degenerative disc disease, grade I spondylolisthesis,
and degenerative scoliosis, the company said in a release.
To be commercialized in Q2 2016, the lumbar cage is
intended for use with autografts and/or allogenic bone grafts, as well
as supplemental spinal fixation systems.
No comments:
Post a Comment